AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE

AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE was reported 258 times

AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WRONG ROUTE 1 0.0385
1 NERVOUS SYSTEM CYST 1 0.0323
2 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
3 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
4 PRODUCT CONTAMINATION CHEMICAL 3 0.0138
5 BURNS THIRD DEGREE 10 0.0095
6 EXPOSURE VIA INHALATION 2 0.0093
7 PRODUCT EXPIRATION DATE ISSUE 10 0.0071
8 APPLICATION SITE PUSTULES 2 0.0055
9 PRODUCT LOT NUMBER ISSUE 12 0.0054
10 POST INFLAMMATORY PIGMENTATION CHANGE 2 0.0044
11 APPLICATION SITE ACNE 2 0.0041
12 PRECANCEROUS SKIN LESION 6 0.0041
13 CHEMICAL BURNS OF EYE 1 0.0036
14 SUSPECTED PRODUCT TAMPERING 2 0.0036
15 PRECANCEROUS CONDITION 2 0.0030
16 SKIN CANCER 58 0.0027
17 PRODUCT BARCODE ISSUE 1 0.0026
18 APPLICATION SITE HYPERSENSITIVITY 3 0.0025
19 APPLICATION SITE SCAR 3 0.0024
20 EXPOSURE VIA EYE CONTACT 1 0.0024
21 MELANOMA RECURRENT 1 0.0024
22 MOLLUSCUM CONTAGIOSUM 1 0.0019
23 CHEMICAL BURN 2 0.0017
24 MONOCLONAL GAMMOPATHY 1 0.0016
25 MALIGNANT MELANOMA 19 0.0014
26 OTITIS MEDIA ACUTE 1 0.0014
27 BASAL CELL CARCINOMA 21 0.0013
28 SUNBURN 10 0.0013
29 APPLICATION SITE BURN 6 0.0012
30 RECALLED PRODUCT ADMINISTERED 11 0.0012
31 APPENDIX CANCER 1 0.0011
32 SQUAMOUS CELL CARCINOMA 8 0.0008
33 BLADDER CANCER STAGE III 1 0.0008
34 XEROSIS 1 0.0008
35 APPLICATION SITE SWELLING 4 0.0008
36 ENDOCRINE DISORDER 1 0.0008
37 APPLICATION SITE REACTION 5 0.0007
38 HAEMATOLOGICAL MALIGNANCY 2 0.0007
39 EXPOSURE TO TOXIC AGENT 2 0.0006
40 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
41 APPLICATION SITE DRYNESS 2 0.0006
42 MILIARIA 1 0.0006
43 RECALLED PRODUCT 1 0.0006
44 PRODUCT CONTAMINATION 2 0.0006
45 APPLICATION SITE DISCOLOURATION 2 0.0005
46 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
47 APPLICATION SITE URTICARIA 1 0.0004
48 PRODUCT LABEL ISSUE 3 0.0004
49 APPLICATION SITE RASH 6 0.0004
50 LIP BLISTER 1 0.0004
51 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
52 BLOOD BLISTER 1 0.0003
53 SWELLING OF EYELID 2 0.0003
54 NEOPLASM MALIGNANT 21 0.0003
55 PNEUMONIA VIRAL 1 0.0003
56 SKIN EROSION 1 0.0003
57 PRODUCT FORMULATION ISSUE 2 0.0003
58 SKIN INJURY 1 0.0003
59 THERMAL BURN 2 0.0003
60 APPLICATION SITE PAIN 6 0.0003
61 ACUTE MYELOID LEUKAEMIA 4 0.0003
62 FURUNCLE 2 0.0003
63 APPLICATION SITE EXFOLIATION 1 0.0002
64 APPLICATION SITE IRRITATION 3 0.0002
65 APPLICATION SITE ERYTHEMA 6 0.0002
66 MELANOCYTIC NAEVUS 1 0.0002
67 LEUKAEMIA 2 0.0002
68 POISONING DELIBERATE 2 0.0002
69 RASH VESICULAR 1 0.0002
70 PHOTOSENSITIVITY REACTION 3 0.0002
71 DERMATITIS CONTACT 2 0.0002
72 URINE ODOUR ABNORMAL 1 0.0002
73 POISONING 2 0.0002
74 APPLICATION SITE VESICLES 1 0.0002
75 PAPULE 1 0.0001
76 SENSITIVE SKIN 1 0.0001
77 ARTHROPOD BITE 1 0.0001
78 EXPIRED PRODUCT ADMINISTERED 4 0.0001
79 PRODUCT CONTAINER ISSUE 1 0.0001
80 SKIN SWELLING 1 0.0001
81 RASH PRURITIC 6 0.0001
82 BRAIN NEOPLASM 1 0.0001
83 BLISTER 6 0.0001
84 PRODUCT PACKAGING ISSUE 1 0.0001
85 EYE INFLAMMATION 1 0.0001
86 COELIAC DISEASE 1 0.0001
87 PRODUCT ODOUR ABNORMAL 1 0.0001
88 APPLICATION SITE PRURITUS 2 0.0001
89 VASCULITIS 1 0.0001
90 RASH ERYTHEMATOUS 4 0.0001
91 ABNORMAL WEIGHT GAIN 1 0.0001
92 DERMATITIS ALLERGIC 1 0.0001
93 BREAST CANCER 7 0.0001
94 SKIN REACTION 1 0.0001
95 PARAESTHESIA ORAL 1 0.0001
96 HYPOAESTHESIA ORAL 1 0.0001
97 SKIN DISCOLOURATION 3 0.0001
98 SKIN EXFOLIATION 5 0.0001
99 SKIN FISSURES 1 0.0001
100 PRODUCT ADMINISTRATION ERROR 1 0.0000
101 RASH 21 0.0000
102 DERMATITIS 1 0.0000
103 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
104 SWELLING FACE 3 0.0000
105 ANGIOEDEMA 2 0.0000
106 RASH PAPULAR 1 0.0000
107 SKIN IRRITATION 2 0.0000
108 ADVERSE EVENT 4 0.0000
109 SKIN BURNING SENSATION 3 0.0000
110 DERMATITIS ATOPIC 2 0.0000
111 PAIN OF SKIN 1 0.0000
112 URTICARIA 6 0.0000
113 RED BLOOD CELL COUNT DECREASED 1 0.0000
114 LACRIMATION INCREASED 1 0.0000
115 HYPERSENSITIVITY 6 0.0000
116 SWOLLEN TONGUE 1 0.0000
117 EYE DISORDER 1 0.0000
118 VIRAL INFECTION 1 0.0000
119 LIP SWELLING 1 0.0000
120 SKIN DISORDER 1 0.0000
121 DRY SKIN 4 0.0000
122 EYE PRURITUS 1 0.0000
123 PRODUCT QUALITY ISSUE 4 0.0000
124 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
125 RASH MACULAR 1 0.0000
126 EYE SWELLING 1 0.0000
127 PLASMA CELL MYELOMA 1 0.0000
128 ERYTHEMA 5 0.0000
129 PRURITUS 9 0.0000
130 RENAL CANCER 1 0.0000
131 PRODUCTIVE COUGH 1 0.0000
132 ECZEMA 1 0.0000
133 EYE PAIN 1 0.0000
134 EYE IRRITATION 1 0.0000
135 BONE PAIN 1 0.0000
136 NASAL CONGESTION 1 0.0000
137 BLADDER CANCER 1 0.0000
138 ILL-DEFINED DISORDER 1 0.0000
139 DISCOMFORT 1 0.0000
140 COUGH 4 0.0000
141 ACNE 1 0.0000
142 PROSTATE CANCER 1 0.0000
143 INFLUENZA LIKE ILLNESS 1 0.0000
144 OROPHARYNGEAL PAIN 1 0.0000
145 CONTUSION 1 0.0000
146 DRUG INEFFECTIVE 13 0.0000
147 ABDOMINAL DISTENSION 1 0.0000
148 HAEMORRHAGE 1 0.0000
149 PALPITATIONS 1 0.0000
150 JOINT SWELLING 1 0.0000
151 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
152 VISUAL IMPAIRMENT 1 0.0000
153 BLOOD PRESSURE INCREASED 1 0.0000
154 PERIPHERAL SWELLING 1 0.0000
155 CONFUSIONAL STATE 1 0.0000
156 CHEST PAIN 1 0.0000
157 DYSPNOEA 3 0.0000
158 GAIT DISTURBANCE 1 0.0000
159 FEELING ABNORMAL 1 0.0000
160 ANXIETY 1 0.0000
161 CONDITION AGGRAVATED 1 0.0000
162 HEADACHE 2 0.0000
163 NAUSEA 2 0.0000
164 VOMITING 1 0.0000
165 DIZZINESS 1 0.0000
166 DIARRHOEA 1 0.0000
167 DEATH 1 0.0000
168 OFF LABEL USE 1 0.0000